Physician profile
Hamid R Sami
NPI 1750327482
$73,489.05
in general payments reported to CMS, 2019-2025
85 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,021 · 2020: $3,040 · 2021: $8,414 · 2022: $11K · 2023: $20K · 2024: $16K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Consulting Fee: $3,320 · Travel and Lodging: $2,104 · Education: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28,245.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,050.00 |
| Consulting Fee | $3,320.00 |
| Travel and Lodging | $2,104.25 |
| Education | $414.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $8,999.68 | 2022-2025 | Quviviq, Quviviq |
| Ipsen Biopharmaceuticals, INC | $8,143.56 | 2019-2025 | Dysport |
| Merz Pharmaceuticals, LLC | $7,331.23 | 2021-2025 | Xeomin |
| Abbvie INC. | $4,727.24 | 2020-2025 | Ubrelvy, Qulipta, Vraylar |
| E.R. Squibb & Sons, L.L.C. | $3,608.60 | 2020-2024 | Zeposia |
| Emd Serono, INC. | $3,553.16 | 2019-2025 | Mavenclad, Mavenclad |
| Argenx US, INC. | $2,139.70 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Novartis Pharmaceuticals Corporation | $2,138.32 | 2019-2025 | |
| Celgene Corporation | $1,798.94 | 2020-2024 | Zeposia |
| Sk Life Science, INC. | $1,797.79 | 2020-2025 | Xcopri |
| Ucb, INC. | $1,796.25 | 2019-2025 | Rystiggo, Zilbrysq, Nayzilam |
| Medtronic USA, INC. | $1,778.43 | 2019 | |
| Genzyme Corporation | $1,472.80 | 2019-2025 | |
| Biogen, INC. | $1,450.52 | 2019-2024 | Vumerity, Tysabri, Avonex |
| Amgen INC. | $1,357.10 | 2020-2025 | Uplizna, Aimovig |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,291.44 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,281.07 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Lilly USA, LLC | $1,171.47 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Genentech USA, INC. | $1,146.03 | 2021-2025 | Ocrevus, Ocrevus Zunovo |
| Amneal Pharmaceuticals LLC | $1,001.23 | 2019-2025 | Crexont, Lyvispah, Rytary |
| Mdd US Operations, LLC | $928.26 | 2019-2025 | Gocovri, Gocovri, Apokyn |
| Tg Therapeutics, INC. | $845.50 | 2023-2025 | |
| Eisai INC. | $709.05 | 2021-2025 | |
| Lundbeck LLC | $702.42 | 2019-2025 | Vyepti, Rexulti |
| Allergan, INC. | $536.39 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $532.96 | 2023-2025 | Rexulti, Nuedexta |
| Alexion Pharmaceuticals, INC. | $531.68 | 2019-2025 | Ultomiris |
| Neurelis, INC. | $475.54 | 2020-2025 | Valtoco |
| Alnylam Pharmaceuticals INC. | $475.14 | 2021-2025 | Onpattro, Amvuttra |
| Neurocrine Biosciences, INC. | $474.50 | 2019-2025 | Ingrezza, Ongentys |
| Biohaven Pharmaceuticals, INC. | $472.56 | 2020-2021 | |
| Kyowa Kirin, INC. | $466.52 | 2020-2025 | Nourianz |
| Takeda Pharmaceuticals U.S.A., INC. | $432.65 | 2022-2025 | Hyqvia |
| Biohaven Pharmaceutical Holding Company Ltd. | $403.07 | 2022 | |
| Xeris Pharmaceuticals, INC. | $396.64 | 2021-2025 | Keveyis, Gvoke Hypopen |
| Jazz Pharmaceuticals INC. | $362.47 | 2020-2025 | |
| Axsome Therapeutics, INC. | $351.60 | 2025 | Symbravo, Sunosi |
| Genentech, INC. | $350.43 | 2024-2025 | Enspryng, Ocrevus |
| Mallinckrodt Hospital Products INC. | $325.34 | 2020-2025 | Acthar |
| Csl Behring | $325.31 | 2019-2025 | Hizentra |
| Tanabe Pharma America, INC. | $321.78 | 2019-2025 | Radicava |
| Grifols USA, LLC | $311.54 | 2019-2025 | Gamunex-C, Xembify |
| Avanir Pharmaceuticals, INC. | $300.05 | 2019-2022 | |
| Acorda Therapeutics, INC | $279.83 | 2019-2023 | Ampyra, Inbrija |
| Horizon Therapeutics Plc | $253.43 | 2022-2023 | Uplizna |
| Sumitomo Pharma America, INC. | $220.28 | 2023-2024 | Aptiom |
| Azurity Pharmaceuticals, INC. | $213.16 | 2023-2025 | Horizant, Horizant |
| Akcea Therapeutics, INC. | $201.96 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $199.43 | 2020-2025 | Ponvory |
| Octapharma USA, INC. | $182.26 | 2024-2025 | Panzyga |
| Sunovion Pharmaceuticals INC. | $172.73 | 2019-2021 | |
| Tonix Medicines, INC. | $172.41 | 2025 | Zembrace Symtouch |
| Janssen Pharmaceuticals, INC | $172.20 | 2022 | |
| Supernus Pharmaceuticals, INC. | $168.93 | 2020-2025 | Qelbree |
| Abbott Laboratories | $168.86 | 2022-2025 | Infinity |
| Upsher-Smith Laboratories LLC | $131.10 | 2022-2023 | |
| Astrazeneca Pharmaceuticals Lp | $125.23 | 2021-2025 | Wainua |
| Cycle Pharmaceuticals INC | $123.95 | 2024-2025 | Tascenso Odt, Bafiertam |
| Amylyx Pharmaceuticals, INC. | $122.06 | 2023 | Relyvrio |
| Adamas Pharmaceuticals, INC. | $120.21 | 2019-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $118.93 | 2024 | Lumryz |
| Acadia Pharmaceuticals INC | $113.25 | 2025 | Nuplazid |
| Scilex Pharmaceuticals INC. | $107.00 | 2019-2023 | Ztlido |
| Currax Pharmaceuticals LLC | $96.25 | 2020-2023 | Onzetra Xsail |
| Harmony Biosciences LLC | $95.90 | 2020-2021 | |
| Boston Scientific Corporation | $88.05 | 2025 | General - Pain Management |
| Impel Pharmaceuticals INC. | $86.23 | 2023 | Trudhesa |
| Merz North America, INC. | $83.97 | 2019-2020 | |
| Ge Healthcare | $69.74 | 2020-2023 | |
| Catalyst Pharmaceuticals, INC. | $68.80 | 2019-2025 | |
| Assertio Therapeutics, INC. | $60.55 | 2019 | |
| Avion Pharmaceuticals | $47.77 | 2022 | |
| Strongbridge US INC. | $47.70 | 2020 | |
| Almatica Pharma LLC | $47.59 | 2021 | |
| Arbor Pharmaceuticals, INC. | $44.27 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $42.61 | 2020 | |
| Ani Pharmaceuticals, INC. | $40.54 | 2025 | Purified Cortrophin Gel |
| Insightec,INC | $34.07 | 2022 | |
| Averitas Pharma INC. | $33.42 | 2024 | Qutenza |
| Collegium Pharmaceutical, INC. | $24.05 | 2022 | |
| Mallinckrodt Enterprises LLC | $21.52 | 2019 | |
| Vertical Pharmaceuticals, LLC | $19.96 | 2019 | |
| Life Molecular Imaging Ltd | $19.59 | 2024 | Neuraceq |
| Gilead Sciences, INC. | $17.64 | 2025 | |
| Impel Pharmaceuticals LLC | $15.66 | 2024 | Trudhesa |
Drugs and devices associated with these payments
Xeomin $7,097Quviviq $6,668Ubrelvy $2,081Kesimpta $1,606Qulipta $1,493Mavenclad $1,223Nurtec Odt $1,035Uplizna $1,034Zavzpret $854Briumvi $846Vumerity $827Ocrevus $775Rexulti $650Gocovri $555Austedo Xr $542Zeposia $489Rystiggo $489Vraylar $484Leqembi $475Botox $438Kisunla $429Vyvgart $409Mayzent $400Tysabri $397Nourianz $387Hyqvia $380Ultomiris $378Panzyga $331Ingrezza $327Symbravo $323Valtoco $308Vyepti $293Keveyis $289Onpattro $275Crexont $268Zilbrysq $250Zembrace Symtouch $231Radicava $222Aptiom $220Horizant $213Acthar $210Ongentys $178Emgality $176Ocrevus Zunovo $171Nayzilam $171Lyvispah $168Briviact $155Epidiolex $154Octagam Immune Globulin (Human) $148Infinity $145Xcopri $140Radicava Ors $135Gamunex-C $127Amvuttra $126Rytary $125Xywav $125Ponvory $125Vyvgart Hytrulo $125Nuedexta $125Tascenso Odt $124Paxlovid $124Relyvrio $122Enspryng $122Dysport $121Qelbree $120Lumryz $119Nuplazid $113Trudhesa $102Bafiertam $102Vyalev $101Aimovig $95.84General - Pain Management $88.05Amyvid $86.04Comirnaty $79.38Ajovy $69.17Fintepla $65.67Tosymra $58.60Hizentra $53.03Duopa $46.25Purified Cortrophin Gel $40.54Reyvow $38.63Firdapse $34.67Qutenza $33.42Sunosi $29.03Xembify $28.86Wainua $23.77Zepbound $22.24Mounjaro $22.24Ztlido $22.21Avonex $21.29Apokyn $20.32Neuraceq $19.59Onzetra Xsail $17.41Ampyra $14.95Inbrija $14.95Gvoke Hypopen $13.24
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Sami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.